Additionally, the reactivation of genes from the otherwise inactive X is being explored as therapy for Rett syndrome, in which affected females are heterozygous for mutations in the MECP2 gene subject to XCI (as discussed above). This evidence concerns the gene MECP2 and Rett syndrome.